This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Training and Resources

Prescribing Information

KEYTRUDA® (pembrolizumab) in advanced Renal Cell Carcinoma (aRCC)

 

More information about KEYTRUDA® (pembrolizumab) in aRCC

Supporting documentation

Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-RCC-00150 | Date of Preparation: July 2020